Schering-Plough Corporation
Schering-Plough Corporation, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in 1851, the company has a rich history marked by significant milestones, including its merger with Merck & Co. in 2009, which expanded its global reach and product portfolio. Schering-Plough is renowned for its innovative solutions in areas such as immunology, oncology, and cardiovascular health. Its core products, including specialty pharmaceuticals and biologics, are distinguished by their commitment to improving patient outcomes through advanced research and development. With a strong market position, Schering-Plough has achieved notable recognition for its contributions to healthcare, making it a trusted name in the industry. The company continues to focus on delivering unique therapies that address unmet medical needs, solidifying its reputation as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does Schering-Plough Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Schering-Plough Corporation's score of 42 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Schering-Plough Corporation's reported carbon emissions
Schering-Plough Corporation, headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may not have publicly committed to specific climate action goals or measurable emissions reductions at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon footprint reduction, indicating a growing trend towards environmental responsibility. However, without specific data or commitments from Schering-Plough, it is challenging to assess their current climate impact or future intentions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Schering-Plough Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
